747 results on '"Lobie, Peter E."'
Search Results
2. Biocompatible wearable touch panel based on ionically conductive organic hydrogels with anti-freezing, anti-dehydration, self-healing, and underwater adhesion properties
3. Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer
4. Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells
5. Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma
6. Pharmacodynamic and pharmacokinetic profiles of a novel GLP-1 receptor biased agonist-SAL0112
7. Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer
8. Oxazine drug-seed induces paraptosis and apoptosis through reactive oxygen species/JNK pathway in human breast cancer cells
9. Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis
10. A novel drug prejudice scaffold-imidazopyridine-conjugate can promote cell death in a colorectal cancer model by binding to β-catenin and suppressing the Wnt signaling pathway
11. Discovery of imidazopyridine-pyrazoline-hybrid structure as SHP-1 agonist that suppresses phospho-STAT3 signaling in human breast cancer cells
12. Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma
13. MAIT cell activation and recruitment in inflammation and tissue damage in acute appendicitis
14. Abstract A008: Pre-diabetic D-glucose exposure promotes EOC progression and cisplatin resistance: Role of BAD associated pathway and potential therapeutic strategy
15. Supplementary Figure S6 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion
16. Table S1 from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion
17. Data from Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion
18. Combined inhibition of BADSer99 phosphorylation and PARP ablates models of recurrent ovarian carcinoma
19. Bead-jet printing enabled sparse mesenchymal stem cell patterning augments skeletal muscle and hair follicle regeneration
20. Development of Novel Pyridine and Pyrimidine Clubbed Bisindoles as Inhibitors of AKT Pathway.
21. Discovery of Piperazin‐2‐yl‐pyrimidines as Anticancer Agents via Targeting JNK Signaling Pathway in Human MCF‐7 Breast Carcinoma.
22. Synthesis of novel triazoles as anticancer agents targeting pJNK in human breast cancer cells.
23. Development of novel indazolyl‐acyl hydrazones as antioxidant and anticancer agent that target VEGFR‐2 in human breast cancer cells
24. Converging neural-centric and mechano-regulation in organoid modeling for system biology and medicine
25. Mitochondria: The metabolic switch of cellular oncogenic transformation
26. Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma
27. An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity
28. Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression
29. Microfluidic Synthesis of Injectable Angiogenic Microgels
30. Electrochemical Synthesis of Versatile Pyrimidine and Oxadiazoles Tethered Triazoles as Inhibitors of VEGFR-2 in Human Breast Cancer Cells
31. Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells
32. Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation
33. Development of Novel Indazolyl‐Acyl Hydrazones as Antioxidant and Anticancer Agents that Target VEGFR‐2 in Human Breast Cancer Cells.
34. Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma.
35. Autocrine/paracrine growth hormone in cancer progression.
36. Development of an Environment-Friendly and Electrochemical Method for the Synthesis of an Oxadiazole Drug-Scaffold That Targets Poly(ADP-Ribose)Polymerase in Human Breast Cancer Cells
37. BAP31 promotes breast cancer progression by interaction with SERCA2
38. Electrochemical Synthesis of New Isoxazoles and Triazoles Tethered with Thiouracil Base as Inhibitors of Histone Deacetylases in Human Breast Cancer Cells
39. Bad phosphorylation as a target of inhibition in oncology
40. The GDNF Family: A Role in Cancer?
41. Long-term pulmonary exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades
42. SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment
43. XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation
44. EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
45. Phenotypic Conversion of Human Mammary Carcinoma Cells by Autocrine Human Growth Hormone
46. LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2
47. Discovery of Pyrimidine- and Coumarin-Linked Hybrid Molecules as Inducers of JNK Phosphorylation through ROS Generation in Breast Cancer Cells
48. Data from PCBP2 Posttranscriptional Modifications Induce Breast Cancer Progression via Upregulation of UFD1 and NT5E
49. Supplementary Data from PAX5α Enhances the Epithelial Behavior of Human Mammary Carcinoma Cells
50. Supplementary Figure 3 from PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.